Loading…
Loading grant details…
| Funder | NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING |
|---|---|
| Recipient Organization | University of Massachusetts Amherst |
| Country | United States |
| Start Date | Apr 01, 2021 |
| End Date | Jan 31, 2025 |
| Duration | 1,401 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10552595 |
Traumatic neural injury causes debilitating and permanent paralysis, in part because chronic inflammation prevents the wound from healing. Our over-arching goal is to design biomaterial strategies for neural repair that instruct remodeling of glial cells – important neural cells capable of regulating inflammation and tissue
regeneration. Glial cells become reactive after injury, propagating and maintaining the pro-inflammatory environment leading to chronic inflammation. Recent studies have shown that these glial cells, namely astrocytes and microglia, can adapt phenotypes for neuroprotection and repair given the right stimuli. In our
own work using a patient-designed model of brain cancer, we found introduction of glial cells to cancer cells significantly alters glial cell reactivity. Cancer cells are known to express matrix proteins and cell-surface glycans that train local cells, including glial cells, to adopt anti-inflammatory phenotypes. We hypothesize that
factors produced by cancer cells may inform design of new materials to retrain reactive glial cells to suppress inflammation and promote repair after injury. To addressing these hypotheses, we will in this proposal 1) characterize expression of extracellular matrix proteins and cell-surface glycans from several patient-derived
brain cancer cells, 2) from this characterization identify potential candidate molecules regulating glial cell phenotype, and 3) screen for ligand combinations inducing anti-inflammatory glial phenotypes under normal and inflamed conditions. This approach will leverage patient-derived glioblastoma cancer cells, two high
throughput biomaterial platforms, and programmable ligands for ‘click’ chemistry to establish the therapeutic potential of using cancer to inform strategies for tissue regeneration. Ultimately, understanding how brain cancer dictates behavior of neural cells, biasing them toward anti-inflammatory phenotypes, will enable
development of materials to instruct remodeling of the injury environment and promote repair, with possibly widespread applications in a number of tissues and pathologies.
University of Massachusetts Amherst
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant